These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11436153)

  • 41. Bizarre lymphoid cells in serous effusion of a dog with mediastinal lymphoma.
    Madewell BR; Jain NC; Padrid P; Danilenko DM
    J Comp Pathol; 1988 Aug; 99(2):229-33. PubMed ID: 3183088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of light and transmission electron microscopy for the evaluation of body cavity effusions.
    Wuerker RB; Guglietti LC; Nations ED
    Acta Cytol; 1983; 27(6):614-24. PubMed ID: 6580794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Misleading morphologic features in cytodiagnosis of serous effusions].
    Liu SF
    Zhonghua Zhong Liu Za Zhi; 1984 Mar; 6(2):106-8. PubMed ID: 6468248
    [No Abstract]   [Full Text] [Related]  

  • 46. [Critical study of 1,000 coelomic serous effusions (author's transl)].
    Saurel J; Baus JP
    Arch Anat Cytol Pathol; 1976; 24(5):385-93. PubMed ID: 1024491
    [No Abstract]   [Full Text] [Related]  

  • 47. [Increase of the asymmetry of distribution of thiourea in the presence of L-phenylalanine].
    Lippe C; Cremaschi D; Capraro V
    Boll Soc Ital Biol Sper; 1964 Dec; 40(23):1569-72. PubMed ID: 5878040
    [No Abstract]   [Full Text] [Related]  

  • 48. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
    Takeshima Y; Amatya VJ; Kushitani K; Kaneko M; Inai K
    Histopathology; 2009 May; 54(6):667-76. PubMed ID: 19438742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
    Tigrani DY; Weydert JA
    Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic value of adenosine deaminase to differentiate exudates and transudates.
    Jadhav AA; Bardapurkar JS
    Indian J Physiol Pharmacol; 2007; 51(2):170-4. PubMed ID: 18175662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
    Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
    Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
    Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
    Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some morphologic features of cells containing PAS positive intracytoplasmic granules in smears of serous effusions.
    Mavrommatis FS
    Acta Cytol; 1964; 8(6):426-30. PubMed ID: 4284354
    [No Abstract]   [Full Text] [Related]  

  • 55. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
    Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
    Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactivity of integrin-linked kinase in human mesothelial cell proliferation.
    Watzka SB; Setinek U; Huber M; Cantonati H; Lax F; Watson S; Weigel G; Müller MR
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):107-10. PubMed ID: 18048409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
    Dejmek A; Hjerpe A
    Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The expression pattern of beta-catenin in mesothelial proliferative lesions and its diagnostic utilities.
    Dai Y; Bedrossian CW; Michael CW
    Diagn Cytopathol; 2005 Nov; 33(5):320-4. PubMed ID: 16240396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of serosal hyperplasia and neoplasia in biopsies.
    McCaughey WT; Al-Jabi M
    Pathol Annu; 1986; 21 Pt 1():271-93. PubMed ID: 2417185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.